Carbocromen Hydrochloride

卡波罗孟

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCarbocromen Hydrochloride
Drug Alias Namecarbocromeno盐酸卡波孟乙氧香豆素carbocromenum乙胺香豆素 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsMyocardial InfarctionCoronary DiseaseAngina Pectoris +[4] 
Global Approved IndicationsMyocardial InfarctionCoronary DiseaseAngina Pectoris +[4] 
Approved Indications in ChinaMyocardial InfarctionCoronary DiseaseAngina Pectoris +[4] 
Original Approved Country/TerritoryMainland China
Original Approved Date1996/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesJiu Tai Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsMyocardial InfarctionCoronary DiseaseAngina Pectoris +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeC01DX05
Related LinksWikipediaKEGG